Health IT vendor Allscripts has partnered with Elligo Health Research to revamp the way clinical trials are done.
Through their alliance, physicians will be able to have a more active say in clinical research. They will be able to conduct such trials in their own clinics and participate as investigators in studies managed by clinical research organizations. Physicians can also glean research revenue, cover trail-related investigator fees and offer new therapies to their patients.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
All this is made possible via the Allscripts eParticipate solution, which allows certain Allscripts clients to become study investigators through Elligo’s services.
eParticipate will be available to organizations using the Allscripts Professional EHR, the Allscripts TouchWorks EHR and Allscripts Sunrise.
Such clients will be able to access clinical trials in various specialties, including pain, urology, pulmonology, gastroenterology, neurology, women’s health and oncology.
“Through our partnership with Allscripts, healthcare providers can identify patients for potential clinical research opportunities directly through their EHR,” Elligo president Chad Moore noted in a statement. “Not only will patients gain access to treatments they might not have had otherwise, they will also participate from the comfort of their own physician’s office.”
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Founded in 2016, Elligo Health Research utilizes healthcare informatics to give clinicians and patients a better chance at participating in clinical trials. By providing clinical research infrastructure technologies, the Austin, Texas-based company plays a key role in accelerating trial enrollment and bringing new products to the healthcare market.
Allscripts will also reap the benefits of the partnership.
“By bringing clinical trials directly to their patients, physicians can remain focused on the direct care of patients while offering them new therapies,” Jay Bhattacharyya, Allscripts senior vice president and general manager of payer and life sciences, noted in a statement. “Physicians will be able to participate in the benefits of clinical research without investing in expensive infrastructure.”
The alliance is another step in an already big summer for the Chicago-based vendor.
Earlier this month, it announced plans to acquire McKesson’s hospital and health system IT business, Enterprise Information Solutions, for $185 million. Through the deal, which is set to close in the fourth quarter of this calendar year, Allscripts will obtain the San Francisco company’s Paragon EHR; lab analytics and blood bank; revenue cycle solutions (STAR and HealthQuest); and content management solution (OneContent).
Photo: FotografiaBasica, Getty Images
